Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check4 days agoChange DetectedRemoved Melanoma, related topics, and MedlinePlus Genetics from the page. This reduces the contextual references for the trial.SummaryDifference0.2%

- Check11 days agoChange DetectedMelanoma and related topics: MedlinePlus Genetics were added to the page. The revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check19 days agoChange DetectedThe study page no longer displays the disease label 'Melanoma' and the related topics link 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check26 days agoChange DetectedMelanoma and related topics such as MedlinePlus Genetics were added as related topics on the page.SummaryDifference0.2%

- Check33 days agoChange DetectedMelanoma and MedlinePlus Genetics were removed from the Related Topics section; these related-topic links are navigational aids rather than core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page; this minor version update does not modify the study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.